Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

At Woman's Hospital in Baton Rouge, lawmakers from Washington D.C. celebrated the start of their "Newborn Essential Support ...

New Delhi, Jan 9 (PTI) Pharma major Eli Lilly and Company on Thursday said it plans to establish a new global capability centre in Hyderabad and hire over 1,000 people to strengthen its digital ...

GLP-1 drugs, initially developed to treat diabetes, help people lose weight ... Retatrutide is currently being developed by Eli Lilly & Co., and is being tested in ongoing clinical trials.

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity. Both are made by Novo Nordisk. Eli Lilly also offers a diabetes ... Drug Administration (FDA).

More than 170 bags were donated to the scheme over the festive period [BBC] A scheme that provided female street sex workers with care kits over the festive period has been so successful it will ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

Eli Lilly is looking to protect its investment by wading into a lawsuit that seeks to allow compounding pharmacies to continue churning out knockoffs to the popular diabetes and obesity drugs.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...